You are here: Industry Insights > cancer

News List

Doubt Over Long-Term Use of Hormone Rx for Recurrent Prostate Cancer drugs
September 18, 2019
Running contrary to current guidelines, new research suggests that use of hormone-suppressing treatment over the long term may not help some men battling recurrent prostate cancer, and may even cause harm.
Gene-targeted cancer drugs, slow release overcome resistance worldpharmanews
September 17, 2019
Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and ...
Delaying Treatment Worsens Head, Neck Cancer Outcomes drugs
September 17, 2019
Delaying time to treatment initiation (TTI) beyond 60 days is associated with decreased overall survival and increased head and neck cancer recurrence
Where Women's Health Clinics Close, Cervical Cancer Outcomes Worsen drugs
September 17, 2019
As government funding dried up and many women's health clinics across America closed, cervical cancer screening rates fell and deaths from the disease rose, a new report shows.
Unique Gene Activity Discovered in People With Both Stroke and Cancer drugs
September 16, 2019
Not all strokes have a clear-cut cause like high blood pressure or smoking. For those so-called cryptogenic strokes, new research suggests cancer might be the trigger ...
Q BioMed, Chemveda Form Cancer Collaboration contractpharma
September 16, 2019
Sign agreement for synthesis and manufacturing of liver cancer chemotherapeutic.
Microrobot could be used to deliver hyperthermia treatment to cancers europeanpharmaceuticalreview
September 12, 2019
A team has developed a microrobot that is effective at targeting specific areas, so could be used in hyperthermia therapies when treating cancers.
Metastatic NSCLC therapy, tepotinib, given Breakthrough Designation europeanpharmaceuticalreview
September 12, 2019
Tepotinib, an investigational therapy for patients with metastatic non-small cell lung cancer has been given Breakthrough Therapy Designation.
Full Chemo Doses May Improve Survival in Breast Cancer drugs
September 12, 2019
Maintaining full doses of chemotherapy, especially early in the treatment course, is important for survival of intermediate or high-risk breast cancer patients...
Nkarta raises $114m to bring cancer therapies into clinic pharmaceutical-technology
September 10, 2019
US-based biopharmaceutical firm Nkarta Therapeutics has raised $114m in series B funding round to advance its natural killer (NK) cell-based cancer drug candidates into clinical trials.